CINECA IRIS Institutional Research Information System

TRECARICHI, ENRICO MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.609
SA - Sud America 1.272
NA - Nord America 838
EU - Europa 452
Continente sconosciuto - Info sul continente non disponibili 200
AF - Africa 77
Totale 5.448
Salva come PNG Salva come JPEG
Nazione #
BR - Brasile 999
US - Stati Uniti d'America 715
SG - Singapore 696
VN - Vietnam 564
CN - Cina 384
HK - Hong Kong 347
BD - Bangladesh 250
IT - Italia 198
KR - Corea 196
DE - Germania 117
AR - Argentina 116
ID - Indonesia 67
MX - Messico 64
EC - Ecuador 62
RU - Federazione Russa 30
ZA - Sudafrica 30
CO - Colombia 28
PY - Paraguay 27
CA - Canada 26
FR - Francia 26
UA - Ucraina 22
CL - Cile 19
PL - Polonia 19
IN - India 18
PK - Pakistan 14
IQ - Iraq 12
TN - Tunisia 12
MA - Marocco 11
JM - Giamaica 8
EG - Egitto 7
NL - Olanda 7
UY - Uruguay 7
UZ - Uzbekistan 7
DO - Repubblica Dominicana 6
GB - Regno Unito 6
PE - Perù 6
VE - Venezuela 6
AL - Albania 5
AZ - Azerbaigian 5
HN - Honduras 4
NP - Nepal 4
PH - Filippine 4
SA - Arabia Saudita 4
SE - Svezia 4
BG - Bulgaria 3
CR - Costa Rica 3
CY - Cipro 3
DZ - Algeria 3
ES - Italia 3
ET - Etiopia 3
KE - Kenya 3
LB - Libano 3
OM - Oman 3
SV - El Salvador 3
TR - Turchia 3
TW - Taiwan 3
AM - Armenia 2
AO - Angola 2
AT - Austria 2
BH - Bahrain 2
BO - Bolivia 2
IE - Irlanda 2
JO - Giordania 2
JP - Giappone 2
KH - Cambogia 2
KW - Kuwait 2
MN - Mongolia 2
MY - Malesia 2
PA - Panama 2
PR - Porto Rico 2
SN - Senegal 2
AE - Emirati Arabi Uniti 1
AG - Antigua e Barbuda 1
BE - Belgio 1
BY - Bielorussia 1
BZ - Belize 1
GA - Gabon 1
GE - Georgia 1
GR - Grecia 1
GT - Guatemala 1
HR - Croazia 1
IL - Israele 1
IR - Iran 1
IS - Islanda 1
KY - Cayman, isole 1
KZ - Kazakistan 1
LV - Lettonia 1
MD - Moldavia 1
MT - Malta 1
NG - Nigeria 1
NI - Nicaragua 1
RE - Reunion 1
RW - Ruanda 1
TH - Thailandia 1
Totale 5.248
Salva come PNG Salva come JPEG
Città #
Hong Kong 347
Ho Chi Minh City 206
Seoul 196
Ashburn 171
Singapore 135
Hanoi 120
Frankfurt am Main 112
San Jose 80
São Paulo 80
Beijing 75
Dallas 63
New York 58
Mexico City 37
Rio de Janeiro 37
Hillsboro 30
Haiphong 23
Santa Clara 23
Thái Bình 23
Buffalo 20
Da Nang 20
Guayaquil 20
Los Angeles 19
Quito 18
Rome 18
Warsaw 18
Naples 17
Campinas 16
Curitiba 16
Jakarta 16
Ribeirão Preto 15
Biên Hòa 14
Brasília 14
Manaus 14
Belo Horizonte 13
Asunción 12
Guarulhos 12
Cape Town 11
Porto Alegre 11
Caxias do Sul 10
Goiânia 10
Hải Dương 10
Johannesburg 10
Milan 10
Ninh Bình 10
Salvador 10
Bắc Ninh 9
Chicago 9
Juiz de Fora 9
Bogotá 8
Bologna 8
Buenos Aires 8
Phủ Lý 8
Santo André 8
Thái Nguyên 8
Baghdad 7
Belém 7
Fortaleza 7
Montevideo 7
Montreal 7
São José do Rio Preto 7
Toronto 7
Can Tho 6
Florence 6
Ha Long 6
Huế 6
Londrina 6
Praia Grande 6
San Juan 6
Santiago 6
Tashkent 6
Baku 5
Bari 5
Cagliari 5
Casablanca 5
Catanduva 5
Catania 5
Ciudad del Este 5
Contagem 5
La Plata 5
Lima 5
Lấp Vò 5
Maricá 5
Piracicaba 5
Recife 5
St Petersburg 5
São Gonçalo 5
Tây Ninh 5
Viamão 5
Vila Velha 5
Bauru 4
Brescia 4
Carapicuíba 4
Charlotte 4
Council Bluffs 4
Duque de Caxias 4
Formosa 4
Genoa 4
Gravataí 4
Houston 4
Hưng Yên 4
Totale 2.517
Salva come PNG Salva come JPEG
Nome #
Acute respiratory distress syndrome after SARS-CoV-2 infection on young adult population: International observational federated study based on electronic health records through the 4CE consortium 69
Long-term kidney function recovery and mortality after COVID-19-associated acute kidney injury: An international multi-centre observational cohort study 67
(1,3)-beta-d-Glucan-based antifungal treatment in critically ill adults at high risk of candidaemia: an observational study 56
Risk factors for the development of hospital-acquired pneumonia in patients with carbapenem-resistant Acinetobacter baumannii respiratory colonization and the role of multisite colonization: a multicenter retrospective study 56
Biofilm production by Candida species and inadequate antifungal therapy as predictors of mortality for patients with candidemia 56
(1,3)-β-d-Glucan-based antifungal treatment in critically ill adults at high risk of candidaemia: an observational study 54
Fungaemia caused by Candida glabrata with reduced susceptibility to fluconazole due to altered gene expression: risk factors, antifungal treatment and outcome 49
A systematic review on antibiotic therapy of cutaneous bacillary angiomatosis not related to major immunocompromising conditions: from pathogenesis to treatment 47
Geographical variation in therapy for bloodstream infections due to multidrug-resistant Enterobacteriaceae: a post-hoc analysis of the INCREMENT study 45
The spike-specific TCRβ repertoire shows distinct features in unvaccinated or vaccinated patients with SARS-CoV-2 infection 44
Tuberculosis and drug resistance in a region of Southern Italy among native and foreign-born populations: A twelve-year province-based study 43
A multinational, preregistered cohort study of β-lactam/β-lactamase inhibitor combinations for treatment of bloodstream infections due to extended-spectrum-β-lactamase-producing enterobacteriaceae 42
COVID-19-associated pulmonary aspergillosis in intensive care unit: A real-life experience 42
Effect of aerosolized colistin as adjunctive treatment on the outcomes of microbiologically documented ventilator-associated pneumonia caused by colistin-only susceptible Gram-negative bacteria 42
Mortality in KPC-producing Klebsiella pneumoniae bloodstream infections: a changing landscape 42
Potential pitfalls in the use of real-world data for studying long COVID 42
HCV antibody prevalence and genotype evolution in a teaching hospital, Calabria Region, southern Italy over a decade (2008-2018) 41
Identification of pmrB mutations as putative mechanism for colistin resistance in A. baumannii strains isolated after in vivo colistin exposure 41
An autochthonous case of cutaneous bacillary angiomatosis not related to major immunosuppression: An emerging or overlooked disease? 40
Persistence of SARS-CoV-2 infection and viral intra- and inter-host evolution in COVID-19 hospitalized patients 40
A Predictive Model of Mortality in Patients With Bloodstream Infections due to Carbapenemase-Producing Enterobacteriaceae 39
Pre-chemotherapy risk factors for invasive fungal diseases: prospective analysis of 1,192 patients with newly diagnosed acute myeloid leukemia (SEIFEM 2010-a multicenter study) 39
Use of Cefiderocol in Adult Patients: Descriptive Analysis from a Prospective, Multicenter, Cohort Study 39
Characterization of long COVID temporal sub-phenotypes by distributed representation learning from electronic health record data: a cohort study 39
Costs of Bloodstream Infections Caused by Escherichia coli and Influence of Extended-Spectrum-beta-Lactamase Production and Inadequate Initial Antibiotic Therapy 38
Evolving phenotypes of non-hospitalized patients that indicate long COVID 38
Superinfections caused by carbapenem-resistant Enterobacterales in hospitalized patients with COVID-19: a multicentre observational study from Italy (CREVID Study) 38
Bacterial Ventilator-Associated Pneumonia in COVID-19 Patients: Data from the Second and Third Waves of the Pandemic 37
Infezioni del cuore e del mediastino 37
Outcome of hbv screening and vaccination in a migrant population in southern italy 36
Utility, acceptability and applicability of a nucleic acid amplification test in comparison with a syndromic approach in the management of sexually transmitted diseases at Mulago National Referral Hospital in Uganda (ASTRHA): protocol for an open-label, randomised controlled trial 36
Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study 36
Direct MALDI-TOF Mass Spectrometry Assay of Blood Culture Broths for Rapid Identification of Candida Species Causing Bloodstream Infections: an Observational Study in Two Large Microbiology Laboratories 35
Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study 35
Risk factors and mortality of healthcare-associated and community-acquired Staphylococcus aureus bacteraemia 35
Clinical phenotypes and outcomes in children with multisystem inflammatory syndrome across SARS-CoV-2 variant eras: a multinational study from the 4CE consortium 35
Role of IgG and IgM and proinflammatory non-specific markers in the diagnosis and prognosis of COVID-19 patients stratified by number of positive SARS-CoV-2 genes 35
Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: risk factors and mortality 35
New advances in management and treatment of multidrug-resistant Klebsiella pneumoniae 35
Excavated pulmonary lesions: differential diagnosis in a health-care worker 35
Predictors of Mortality in Bloodstream Infections Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae: Importance of Combination Therapy 35
A multicenter study of septic shock due to candidemia: outcomes and predictors of mortality 34
Efficacy and durability of two- vs. three-drug integrase inhibitor-based regimens in virologically suppressed HIV-infected patients: Data from real-life ODOACRE cohort 34
Risk factors for hepatitis B and C among healthy population: a community-based survey from four districts of Southern Italy 33
Effect of directly acting antivirals for hepatitis C virus infection on proprotein convertase subtilisin/kexin type 9 level 33
SARS CoV-2 spike protein-guided exosome isolation facilitates detection of potential miRNA biomarkers in COVID-19 infections 33
RAAS inhibitors are not associated with mortality in COVID-19 patients: findings from an observational multicenter study in Italy and a meta-analysis of 19 studies 33
Risk factors and outcomes of candidemia caused by biofilm-forming isolates in a tertiary care hospital 33
Antibiotic Treatment of Carbapenem-Resistant Acinetobacter baumannii Infections in View of the Newly Developed β-Lactams: A Narrative Review of the Existing Evidence 32
Predictors of Mortality in Patients with Bloodstream Infections Caused by Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae: Importance of Inadequate Initial Antimicrobial Treatment 31
Bloodstream infections in haematological cancer patients colonized by multidrug-resistant bacteria 31
Lights and Shadows of Long COVID: Are Latent Infections the Real Hidden Enemy? 31
Analysis of the persistence time of the SARS-CoV-2 virus in the cadaver and the risk of passing infection to autopsy staff 30
Spike-specific T-cell responses in patients with COVID-19 successfully treated with neutralizing monoclonal antibodies against SARS-CoV-2 30
Clinical Characteristics and Outcome of Hospitalized COVID-19 Patients Treated with Standard Dose of Dexamethasone or High Dose of Methylprednisolone 30
Early initiation of combined therapy in severely immunocompromised patients with COVID-19: a retrospective cohort study 30
Intravenous Fosfomycin: The Underdog Player in the Treatment of Carbapenem-resistant Acinetobacter baumannii Infections 30
Antimicrobial-resistant Gram-negative bacteria in febrile neutropenic patients with cancer: current epidemiology and clinical impact 30
Understanding cutaneous tuberculosis: two clinical cases 29
Dynamics of Viral Infection and Evolution of SARS-CoV-2 Variants in the Calabria Area of Southern Italy 29
Ertapenem for the treatment of bloodstream infections due to ESBL-producing Enterobacteriaceae: A multinational pre-registered cohort study 29
The Effect of Polymorphisms in Candidate Genes on the Long-Term Risk of Lipodystrophy and Dyslipidemia in HIV-Infected White Patients Starting Antiretroviral Therapy 29
Publisher Correction: Lessons learned and implications of early therapies for coronavirus disease in a territorial service centre in the Calabria region: a retrospective study 29
Role of IgG and IgM and proinflammatory aspecific markers in the diagnosis and prognosis of COVID-19 patients stratified by number of positive SARS-CoV-2 genes 29
Effect of combination therapy containing a high-dose carbapenem on mortality in patients with carbapenem-resistant Klebsiella pneumoniae bloodstream infection 29
Clinical aspects and predictors of mortality of Pseudomonas aeruginosa pneumonia in a cohort of critically ill patients 29
Are we doing enough for controlling tuberculosis and multi-drug resistance in an epicenter of the current migration emergency (Calabria Region, Southern Italy)? 29
Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian CORIST Study 29
Predictors of mortality in multidrug-resistant Klebsiella pneumoniae bloodstream infections 29
Ceftolozane/tazobactam for difficult-to-treat Pseudomonas aeruginosa infections: A systematic review of its efficacy and safety for off-label indications 28
EFFICACY OF CEFIDEROCOL- VERSUS COLISTIN-CONTAINING REGIMEN FOR TREATMENT OF BACTEREMIC VENTILATOR-ASSOCIATED PNEUMONIA CAUSED BY CARBAPENEM-RESISTANT ACINETOBACTER BAUMANNII IN COVID-19 PATIENTS 28
Sex-Specific HLA Alleles Contribute to the Modulation of COVID-19 Severity 28
Weight of Clinical and Social Determinants of Metabolic Syndrome in People Living with HIV 28
EVALUATION OF IL-35, AS A POSSIBLE BIOMARKER FOR FOLLOW-UP AFTER THERAPY, IN CHRONIC HUMAN SCHISTOSOMA INFECTION 28
Bloodstream infections caused by Escherichia coli in onco-haematological patients: Risk factors and mortality in an Italian prospective survey 28
Circulation of a Unique Klebsiella pneumoniae Clone, ST147 NDM-1/OXA-48, in Two Diverse Hospitals in Calabria (Italy) 28
Epidemiology, Species Distribution, Antifungal Susceptibility, and Outcome of Candidemia across five sites in Italy and Spain 28
A case report of pneumomediastinum in a COVID-19 patient treated with high-flow nasal cannula and review of the literature: Is this a “spontaneous” complication? 28
Intravenous fosfomycin for treatment of severe infections caused by carbapenem-resistant Acinetobacter baumannii: A multi-centre clinical experience 28
Evolution of in-hospital patient characteristics and predictors of death in the COVID-19 pandemic across four waves: are they moving targets with implications for patient care? 28
Safety and Effectiveness of Transvenous Lead Extraction in Octogenarians 28
The Spread of SARS-CoV-2 Omicron Variant in CALABRIA: A Spatio-Temporal Report of Viral Genome Evolution 27
Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohort 27
Reply to "Identifying Patients Harboring Extended-Spectrum-beta-Lactamase-Producing Enterobacteriaceae on Hospital Admission Is Not That Simple" 27
Listeria infection after treatment with alemtuzumab: A case report and literature review. would antibiotic prophylaxis be considered? 27
Enzyme-Linked Immunospot Assay as a Complementary Method to Assess and Monitor Cytomegalovirus Infection in Kidney Transplant. Recipients on Pre-emptive Antiviral Therapy: A Single-Center Experience 27
Evaluation of the Practice of Antifungal Prophylaxis Use in Patients With Newly Diagnosed Acute Myeloid Leukemia: Results From the SEIFEM 2010-B Registry 27
Insights into reasons for discontinuation according to year of starting first regimen of highly active antiretroviral therapy in a cohort of antiretroviral-naive patients 27
Ceftazidime-avibactam use for klebsiella pneumoniae carbapenemase-producing k. pneumoniae infections: A retrospective observational multicenter study 27
Uncommon mold infections in hematological patients: epidemiology, diagnosis and treatment 27
Spontaneous and severe haematomas in patients with COVID-19 on low-molecular-weight heparin for paroxysmal atrial fibrillation 26
Considerations on antimicrobial prophylaxis in patients with lymphoproliferative diseases: A SEIFEM group position paper 26
INTERLEUKIN-62/LYMPHOCYTE AS A PROPOSED PREDICTIVE INDEX FOR COVID-19 PATIENTS TREATED WITH MONOCLONAL ANTIBODIES 26
Disentangling the Association of Hydroxychloroquine Treatment with Mortality in Covid-19 Hospitalized Patients through Hierarchical Clustering 26
Characteristics, outcome and predictors of in-hospital mortality in an elderly population from a SARS-CoV-2 outbreak in a long-term care facility 26
Factors associated with mortality in bacteremic patients with hematologic malignancies 26
International comparisons of laboratory values from the 4CE collaborative to predict COVID-19 mortality 26
Pharmacokinetics of etravirine in HIV-infected patients concomitantly treated with rifampin for tuberculosis 26
Carbapenemase-producing Klebsiella pneumoniae and hematologic malignancies 26
EVALUATION OF IL-35, AS A POSSIBLE BIOMARKER FOR FOLLOW-UP AFTER THERAPY, IN CHRONIC HUMAN SCHISTOSOMA INFECTION 26
Totale 3.421
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.183
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.183
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/202520 0 0 0 0 0 0 0 0 0 0 0 20
2025/20265.315 754 119 875 1.380 426 62 147 377 238 329 380 228
2026/2027113 88 25 0 0 0 0 0 0 0 0 0 0
Totale 5.448